Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws

Osteoporosis International

Volumn 24, Issue 8, 2013, Pages 2365-2369

  Yoshiga, D ^a   Yamashita, Y ^b   Nakamichi, I ^a   Tanaka, T ^a   Yamauchi, K ^a   Yamamoto, N ^c   Nogami, S ^a   Kaneuji, T ^a   Mitsugi, S ^a   Sakurai, T ^a   Kiyomiya, H ^a   Tominaga, K ^a   Morimoto, Y ^a   Takahashi, T ^a,d  

^a KYUSHU DENTAL COLLEGE   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

^c OITA UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Bisphosphonate; Osteonecrosis; P1NP; s NTX; Teriparatide

Indexed keywords

ALENDRONIC ACID; AMINO TERMINAL TELOPEPTIDE; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN; N TERMINAL PROPEPTIDE OF TYPE I COLLAGEN; PARATHYROID HORMONE[1-34]; UNCLASSIFIED DRUG;

AGED; ARTICLE; BONE REGENERATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONSULTATION; DEBRIDEMENT; FEMALE; FISTULA; GARGLE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; JAPANESE; JAW MOVEMENT; JAW OSTEONECROSIS; MANDIBLE FRACTURE; MAXILLA SINUSITIS; MEDICAL RECORD; MOUTH HYGIENE; PERIODONTAL DISEASE; PRIORITY JOURNAL; SOFT TISSUE INFECTION; TREATMENT DURATION; TREATMENT REFUSAL;

AGED, 80 AND OVER; BIOLOGICAL MARKERS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; TERIPARATIDE; TREATMENT OUTCOME;

EID: 84880297624     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2277-x     Document Type: Article

References (13)

1. Franken AA, van Blijderveen NJ, Witjes MJ, Netelenbos CJ (2011) Bisphosphonate-related osteonecrosis of the jaw. Ned Tijdschr Geneeskd 155:A3077
2. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update. J Oral Maxillofac Surg 67:2-12
3. Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y, Fujita T, Shiraki M (2012) Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 97(9):3097-3106
4. Reid IR, Cornish J (2011) Epidemiology and pathogenesis of osteonecrosis of the jaw. Nat Rev Rheumatol 8:90-96
5. Kyrgidis A, Vahtsevanos K (2010) Osteonecrosis of the jaw in patients receiving oral bisphosphonates. Osteoporos Int 21:535-536
6. Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753-761
7. Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR (2010) Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dent 30:77-82
8. Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363:2473-2474
9. Lau AN, Adachi JD (2009) Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol 36:1835-1837
10. Lee JJ, Cheng SJ, Jeng JH, Chiang CP, Lau HP, Kok SH (2011) Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck 33:1366-1371
11. Kyrgidis A, Antoniades K (2011) Could teriparatide be the treatment for osteonecrosis of the jaws? Head Neck 33:1382-1383, Author reply, 1383
12. Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 65:573-580
13. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932-1941